Cargando…

Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective study

BACKGROUND: A single-institutional prospective study of optimal hypofractionated conformal radiotherapy for large brain metastases with high risk factors was performed based on the risk prediction of radiation-related complications. METHODS: Eighty-eight patients with large brain metastases ≥10 cm(3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Hiroshi K, Sato, Hiro, Suzuki, Yoshiyuki, Saitoh, Jun-ichi, Noda, Shin-ei, Seto, Ken-ichi, Torikai, Kota, Sakurai, Hideyuki, Nakano, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203932/ https://www.ncbi.nlm.nih.gov/pubmed/25322826 http://dx.doi.org/10.1186/s13014-014-0231-5

Ejemplares similares

Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis
por: Inoue, Hiroshi K., et al.
Publicado: (2014)

Image Fusion for Radiosurgery, Neurosurgery and Hypofractionated Radiotherapy
por: Inoue, Hiroshi K, et al.
Publicado: (2015)

Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14)
por: Inoue, Hiroshi K., et al.
Publicado: (2013)

Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results
por: Oike, Takahiro, et al.
Publicado: (2013)

Hypofractionated Radiotherapy for 35 Patients with Adrenal Metastases: A Single-Institution Experience
por: Zhao, Ruizhi, et al.
Publicado: (2020)

Translational Research to Improve the Efficacy of Carbon Ion Radiotherapy: Experience of Gunma University
por: Oike, Takahiro, et al.
Publicado: (2016)

RT-03 POSTOPERATIVE CYBERKNIFE HYPOFRACTIONATED RADIOTHERAPY FOR THE ELDERLY PATIENTS WITH GLIOBLASTOMA
por: Tabei, Yusuke, et al.
Publicado: (2019)

Predictive factors of acute skin reactions to carbon ion radiotherapy for the treatment of malignant bone and soft tissue tumors
por: Takakusagi, Yosuke, et al.
Publicado: (2017)

Outcomes of Hypofractionated Stereotactic Radiotherapy for Small and Moderate-Sized Brain Metastases: A Single-Institution Analysis
por: Yan, Michael, et al.
Publicado: (2022)

Efficacy and Feasibility of Salvage Re-Irradiation with CyberKnife for In-Field Neck Lymph Node Recurrence: A Retrospective Study
por: Kobayashi, Daijiro, et al.
Publicado: (2019)

An abscopal effect in a case of concomitant treatment of locally and peritoneally recurrent gastric cancer using adoptive T‐cell immunotherapy and radiotherapy
por: Sato, Hiro, et al.
Publicado: (2017)

Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
por: Saitoh, Jun‐ichi, et al.
Publicado: (2019)

Radio-sensitization effect of an mTOR inhibitor, temsirolimus, on lung adenocarcinoma A549 cells under normoxic and hypoxic conditions
por: Ushijima, Hiroki, et al.
Publicado: (2015)

Hypofractionated Stereotactic Radiotherapy with CyberKnife for Large Arteriovenous Malformations and Arteriovenous Malformations Located in Eloquent Areas
por: NIWA, Ryoko, et al.
Publicado: (2022)

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
por: Kawamura, Hidemasa, et al.
Publicado: (2020)

Multi‐institutional retrospective study of mucoepidermoid carcinoma treated with carbon‐ion radiotherapy
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
por: Jiang, Xue-song, et al.
Publicado: (2012)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Stereotactic body radiotherapy for adenoid cystic carcinoma metastatic to the lung: a case report
por: Kobayashi, Daijiro, et al.
Publicado: (2021)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model
por: Yoshimoto, Yuya, et al.
Publicado: (2014)

Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study
por: Takakusagi, Yosuke, et al.
Publicado: (2019)

Dosimetric comparison of three-dimensional conformal radiotherapy versus volumetric-arc radiotherapy in cervical cancer treatment: applying the central-shielding principle to modern technology
por: Tamaki, Tomoaki, et al.
Publicado: (2018)

Hypofractionated radiotherapy in breast cancer: a 10-year single institution experience
por: Najas, Gabriel Faria, et al.
Publicado: (2021)

Hypofractionated Post-Prostatectomy Radiotherapy in 16 Fractions: A Single-Institution Outcome
por: Dubinsky, Pavol, et al.
Publicado: (2023)

Treatment of Single or Multiple Brain Metastases by Hypofractionated Stereotactic Radiotherapy Using Helical Tomotherapy
por: Nagai, Aiko, et al.
Publicado: (2014)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach
por: Märtens, Bettina, et al.
Publicado: (2012)

Evaluation of efficacy and safety of robotic stereotactic body radiosurgery and hypofractionated stereotactic radiotherapy for vertebral metastases
por: Księżniak-Baran, Dorota, et al.
Publicado: (2015)

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)
por: Lesueur, Paul, et al.
Publicado: (2018)

Brain metastases: Single-dose radiosurgery versus hypofractionated stereotactic radiotherapy: A retrospective study
por: de la Pinta, Carolina, et al.
Publicado: (2020)

Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation
por: Mengue, Laurence, et al.
Publicado: (2020)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Dose–volume histogram parameters of high-dose-rate brachytherapy for Stage I–II cervical cancer (≤4cm) arising from a small-sized uterus treated with a point A dose-reduced plan
por: Nakagawa, Akiko, et al.
Publicado: (2014)

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial
por: Lazzari, Grazia, et al.
Publicado: (2017)

Review of Hypofractionated Radiotherapy for Prostate Cancer
por: Spyropoulou, Despina, et al.
Publicado: (2012)

The Role of Hypofractionated Radiotherapy in Prostate Cancer
por: Benjamin, Linus C., et al.
Publicado: (2017)

Cost Minimization Analysis of Hypofractionated Radiotherapy
por: Yaremko, Hannah L., et al.
Publicado: (2021)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dt9vjmdv4b0tm3t396n1rt5484